Share on Pinterest

GLP-1 medications , such as Ozempic and Wegovy, have skyrocketed in popularity and are used to treat type 2 diabetes and aid in weight loss.

However, studies show they do not work for everyone, especially when it comes to weight loss.

A new study found that a new type of medication , called eloralintide, which targets a different hormone called amylin, helped people achieve meaningful weight loss.

According to the World Obesity Federation, as of 2024, about 3 billion people around the world were overweight or obese .

To help in the fight against obesity, medications for weight loss have skyrocketed in popularity over the last few years. A 2024 poll found that about one in eight adults have ever taken a glucagon-like peptide-1 (GLP-1) recep

See Full Page